MedPath

Comparing hormone profile and outcomes of ovulation triggering with GnRH and HGC in IVF

Phase 2
Conditions
Female infertility.
Female infertility
Registration Number
IRCT2015060222541N1
Lead Sponsor
Vice Chancellor of Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
232
Inclusion Criteria

All patients who are candidate for IVF/ICSI( Male factor infertility, unexplained infertility, tubal factor infertility), Age below 39 years old, BMI: 18-29, Regular menstrual cycles.Agreement of patient to enrol the research

Exclusion criteria: Ovulatory factor infertility, Endometriosis, Uterine anomalies, Age above 39 years old, Non-agreement of patient to enrol the research

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber and Quality of oocytes retrieved in each IVF cycle. Timepoint: on day of ovum pick up. Method of measurement: measuring number and quality of oocytes on the day of pick up by pathologist in lab under microscope and scoring.;Progesterone level. Timepoint: on the day of injection HCG or GnRH agonist(Final Triggering) and rechecked 7 and 14 days after that. Method of measurement: Serum Level, Lab test.;Number and Quality of embryos transferred in IVF cycle. Timepoint: on day of embryo transfer. Method of measurement: measuring number and quality of embryos by pathologist in lab under microscope and grading.;Comparing FSH, LH, Estradiol and HCG in both groups. Timepoint: on days 2 and 6 of menstrual cycle, final oocyte triggering, oocyte retrieval, 7 and 14 days after that oocyte retrieved. Method of measurement: Serum Level, Lab test.
Secondary Outcome Measures
NameTimeMethod
Rate of ovarian hyperstimulation syndrome (OHSS). Timepoint: From day of HCG or GnRH agonist injection up to 2 weeks later. Method of measurement: Clinical management of symptoms, Sonography.;Clinical Pregnancy. Timepoint: 16 days after triggering if menstruation was absent. Method of measurement: Serum BHCG and TVS.
© Copyright 2025. All Rights Reserved by MedPath